---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-095869"
form_type: "8-K"
ticker: "KMTS"
cik: "0001877184"
company_name: "KESTRA MEDICAL TECHNOLOGIES, LTD."
filed_at: "2025-07-15T23:59:59+00:00"
generated_at: "2026-05-18T06:32:25.086856+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Kestra Medical Q4 rev $17.2M (+71%), FY rev $59.8M (+115%); guides FY26 $85M

## Summary
- Q4 revenue $17.2M (+71% YoY); FY25 revenue $59.8M (+115% YoY).
- Q4 gross margin 44.3% vs 13.9% prior year; FY gross margin 40.5% vs 1.3%.
- Q4 prescriptions: 3,903 (+43% YoY); FY prescriptions: 13,193 (+72% YoY).
- FY26 revenue guidance initiated at $85M, representing 42% growth over FY25.
- GAAP net loss $51.1M in Q4; adjusted EBITDA loss $20.3M; cash $237.6M.

## SEC filing metadata
- accession: 0000950170-25-095869
- form_type: 8-K
- ticker: KMTS
- cik: 0001877184
- company_name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- filed_at: 2025-07-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877184/000095017025095869/0000950170-25-095869-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877184/000095017025095869/ck0001877184-20250715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-095869
- JSON: https://secwatch.observer/filing/0000950170-25-095869.json
- Plain text: https://secwatch.observer/filing/0000950170-25-095869.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.